Fixed-dose confidence
Our fixed-dose pen, Quanta, removes dose-selection choices and provides a consistent cadence for each injection.
With the rising demand for effective self-injection solutions in cardiometabolic care, SHL Medical’s pen injector portfolio is purpose-built to support this evolving field, delivering precision, ease of use, and scalability for modern therapies.
Pen injectors are devices designed for medicines that are taken repeatedly over time. They usually hold a cartridge with multiple doses inside. With each use, the user typically attaches a needle, prepares the next dose (often by dialing or setting it), and injects subcutaneously supporting a repeatable routine across a treatment program. This is in contrast to autoinjectors, which contain a pre-filled container with a single, pre-set medication dose.
As a pioneer of modern self-injection solutions, SHL has been at the forefront of the drug delivery industry, setting trends and shaping standards in device development and manufacturing. While Quanta is our newest pen platform, SHL Medical has supported pen injection solutions across multiple therapy areas.